Global Facial Injectable Market is valued at approximately USD 13.4 billion in 2021 and is anticipated to grow with a healthy growth rate of more than 8.8% over the forecast period 2022-2028. Facial Injectable rejuvenates the facial skin by reducing wrinkles, raising scar depressions, improving physical appearance and enhancing the lips. The increasing demand for skincare due to consumer awareness drives the market growth across the forecast period. According to Statista, the value of global skincare market increased from 2018 i.e., USD 134.5 Billion to USD 148.3 Billion in 2020 and is further expected to reach USD 189.3 billion by 2025. The other driving factor for the market growth is the launch of new products. For instance, in December 2020, Aesthetics innovators launched injectables for face and body including filler for the body. Likewise, in October 2021, Merz launched the Belotero Lips, for lip enhancement and perioral lines treatment. Also, increasing awareness regarding physical appearance and rising adoption of minimally invasive surgeries for skin treatment is likely to increase the market growth during the forecast period. However, high cost of products impedes the growth of the market over the forecast period of 2022-2028.
The key regions considered for the global Facial Injectable market study include Asia Pacific, North America, Europe, Latin America and Rest of the World. North America is the leading region across the world in terms of market share owing to the growing geriatric population and high demand for cosmetic surgery products. Whereas, Asia-Pacific is anticipated to exhibit the highest growth rate over the forecast period 2022-2028 due to rise in consumer awareness and rise in disposable income along with growing trend for physical appearance.

Major market players included in this report are:
Hologic (cynosure)
Johnson & Johnson
Solta Medical
Syneron Candela
Alma Laser
Medytox Inc.
Merz Pharma

The objective of the study is to define market sizes of different segments & countries in recent years and to forecast the values to the coming eight years. The report is designed to incorporate both qualitative and quantitative aspects of the industry within each of the regions and countries involved in the study. Furthermore, the report also caters the detailed information about the crucial aspects such as driving factors & challenges which will define the future growth of the market. Additionally, the report shall also incorporate available opportunities in micro markets for stakeholders to invest along with the detailed analysis of competitive landscape and product offerings of key players. The detailed segments and sub-segment of the market are explained below:
By Product:
Hyaluronic Acid
Botulinum Toxin Type A
By Application:
By Region:
North America

Asia Pacific
South Korea
Latin America
Rest of the World

Furthermore, years considered for the study are as follows:

Historical year – 2018, 2019, 2020
Base year – 2021
Forecast period – 2022 to 2028

Target Audience of the Global Facial Injectable Market in Market Study:

Key Consulting Companies & Advisors
Large, medium-sized, and small enterprises
Venture capitalists
Value-Added Resellers (VARs)
Third-party knowledge providers
Investment bankers